This HTML5 document contains 39 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dctermshttp://purl.org/dc/terms/
n13http://localhost/temp/predkladatel/
n4http://linked.opendata.cz/resource/domain/vavai/riv/tvurce/
n5http://linked.opendata.cz/ontology/domain/vavai/
shttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
n3http://linked.opendata.cz/ontology/domain/vavai/riv/
n2http://linked.opendata.cz/resource/domain/vavai/vysledek/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n6http://linked.opendata.cz/ontology/domain/vavai/riv/klicoveSlovo/
n14http://linked.opendata.cz/ontology/domain/vavai/riv/duvernostUdaju/
n16http://linked.opendata.cz/resource/domain/vavai/vysledek/RIV%2F61988987%3A17110%2F02%3AA1000VS0%21RIV10-MSM-17110___/
xsdhhttp://www.w3.org/2001/XMLSchema#
n10http://linked.opendata.cz/ontology/domain/vavai/riv/aktivita/
n9http://linked.opendata.cz/ontology/domain/vavai/riv/jazykVysledku/
n17http://linked.opendata.cz/ontology/domain/vavai/riv/obor/
n12http://linked.opendata.cz/ontology/domain/vavai/riv/druhVysledku/
n15http://reference.data.gov.uk/id/gregorian-year/

Statements

Subject Item
n2:RIV%2F61988987%3A17110%2F02%3AA1000VS0%21RIV10-MSM-17110___
rdf:type
n5:Vysledek skos:Concept
dcterms:description
Background: Multiple myeloma (MM) is a very heterogeneous disease requiring a choice of individual therapy with intensity respecting the prognostic evaluation of the patient. Type of study andgroup of patients: In the group of 237 patients with MM treated between 1991-2002 by conventional therapy prognostic value and practical utility of seven selected staging systems were assessed. Background: Multiple myeloma (MM) is a very heterogeneous disease requiring a choice of individual therapy with intensity respecting the prognostic evaluation of the patient. Type of study andgroup of patients: In the group of 237 patients with MM treated between 1991-2002 by conventional therapy prognostic value and practical utility of seven selected staging systems were assessed.
dcterms:title
Prognostic factors and clinical staging systems in multiple myeloma in the group of 237 patients from the years 1991-2002 treated with conventional chemotherapy II. Prognostic significance of some existing staging systems Prognostic factors and clinical staging systems in multiple myeloma in the group of 237 patients from the years 1991-2002 treated with conventional chemotherapy II. Prognostic significance of some existing staging systems
skos:prefLabel
Prognostic factors and clinical staging systems in multiple myeloma in the group of 237 patients from the years 1991-2002 treated with conventional chemotherapy II. Prognostic significance of some existing staging systems Prognostic factors and clinical staging systems in multiple myeloma in the group of 237 patients from the years 1991-2002 treated with conventional chemotherapy II. Prognostic significance of some existing staging systems
skos:notation
RIV/61988987:17110/02:A1000VS0!RIV10-MSM-17110___
n3:aktivita
n10:S
n3:aktivity
S
n3:cisloPeriodika
15
n3:dodaniDat
n15:2010
n3:domaciTvurceVysledku
n4:3867781 n4:1383914
n3:druhVysledku
n12:J
n3:duvernostUdaju
n14:S
n3:entitaPredkladatele
n16:predkladatel
n3:idSjednocenehoVysledku
660626
n3:idVysledku
RIV/61988987:17110/02:A1000VS0
n3:jazykVysledku
n9:eng
n3:klicovaSlova
%22International Prognostic Index%22; Clinical staging systems; Multiple myeloma; New independent prognostic factors
n3:klicoveSlovo
n6:New%20independent%20prognostic%20factors n6:Multiple%20myeloma n6:%2522International%20Prognostic%20Index%2522 n6:Clinical%20staging%20systems
n3:kodStatuVydavatele
CZ - Česká republika
n3:kontrolniKodProRIV
[20AE4C23ED6D]
n3:nazevZdroje
Klinická onkologie
n3:obor
n17:FE
n3:pocetDomacichTvurcuVysledku
2
n3:pocetTvurcuVysledku
2
n3:rokUplatneniVysledku
n15:2002
n3:svazekPeriodika
suppl.
n3:tvurceVysledku
Gumulec, Jaromír Martínek, Arnošt
s:issn
0862-495X
s:numberOfPages
6
n13:organizacniJednotka
17110